-transparent.png){kind=logo}
Specific antagonists of tumour necrosis factor (TNF-alpha) have rapidly gained popularity for the treatment of rheumatoid arthritis and ankylosing spondylitis (AS). Reported side effects from these agents include drug-induced autoimmune disorders. The monoclonal antibody against TNF-alpha, infliximab, has been associated with induction of systemic lupus erythematosus (SLE) in only one patient with AS in the literature. However, there have been no published reports of drug induced lupus-like syndrome (LLS) with positive anti-histone antibodies. We describe a 59-year-old woman with a 12-year history of refractory axial AS who developed signs and symptoms of LLS during treatment with infliximb with positive antinuclear and anti-histone antibodies. On diagnosis of LLS, infliximab was discontinued and the LLS-related symptoms promptly resolved.
A Mounach, and
M Ghazi, and
A Nouijai, and
I Ghozlani, and
L Achemlal, and
A Bezza, and
A El Maghraoui
February 2009,
Rheumatology international,
A Mounach, and
M Ghazi, and
A Nouijai, and
I Ghozlani, and
L Achemlal, and
A Bezza, and
A El Maghraoui
January 2006,
Rheumatology (Oxford, England),
A Mounach, and
M Ghazi, and
A Nouijai, and
I Ghozlani, and
L Achemlal, and
A Bezza, and
A El Maghraoui
March 2014,
Rheumatology international,
A Mounach, and
M Ghazi, and
A Nouijai, and
I Ghozlani, and
L Achemlal, and
A Bezza, and
A El Maghraoui
August 2006,
Current rheumatology reports,
A Mounach, and
M Ghazi, and
A Nouijai, and
I Ghozlani, and
L Achemlal, and
A Bezza, and
A El Maghraoui
July 2015,
BMC musculoskeletal disorders,
A Mounach, and
M Ghazi, and
A Nouijai, and
I Ghozlani, and
L Achemlal, and
A Bezza, and
A El Maghraoui
January 2010,
Reumatismo,
A Mounach, and
M Ghazi, and
A Nouijai, and
I Ghozlani, and
L Achemlal, and
A Bezza, and
A El Maghraoui
September 2017,
The Korean journal of internal medicine,
A Mounach, and
M Ghazi, and
A Nouijai, and
I Ghozlani, and
L Achemlal, and
A Bezza, and
A El Maghraoui
January 2005,
Drugs,
A Mounach, and
M Ghazi, and
A Nouijai, and
I Ghozlani, and
L Achemlal, and
A Bezza, and
A El Maghraoui
January 2014,
International journal of clinical and experimental medicine,
A Mounach, and
M Ghazi, and
A Nouijai, and
I Ghozlani, and
L Achemlal, and
A Bezza, and
A El Maghraoui
January 2008,
Dermatology (Basel, Switzerland),
